Nachrichten zur Viking Therapeutics Inc. Aktie

Why Viking Therapeutics Stock Bumped 3% Higher Today

A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX)…

Why Weight-Loss Developer Stocks Tumbled on Tuesday

Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, werent looking so hot on the stock…

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds…

3 Monster Stocks in the Making

Think of some of the biggest and most successful stocks on the market. Now, go back 20 or 30 years.…

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

One of the best catalysts for a stocks rise is the withdrawal of a rival. That was an important dynamic…

Why Viking Therapeutics Stock Was Victorious This Week

Viking Therapeutics (NASDAQ: VKTX), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was…

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

GLP-1 drug prices are falling. Thats good news for patients, but perhaps not such good news for pharmaceutical stock investors.…

Is Novo Nordisk Stock a Buy?

For years, Denmark-based Novo Nordisk (NYSE: NVO) was a fairly traditional develop-and-market pharmaceutical company that escaped notice by many investors.…

1 Beaten-Down Stock to Buy and Hold for 10 Years

Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent…

Why Viking Therapeutics Stock Popped Today

2025 is the year we learn whether Viking Therapeutics stock will be a winner.…

Think Its Too Late to Buy Novo Nordisk? Heres the Biggest Reason Why Theres Still Time.

Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of…

Did Eli Lilly Just Say Checkmate to Novo Nordisk?

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around…

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $23.94, representing a +1.44% change from its previous close.…

2 Stocks Down by 25% or More This Year to Buy and Hold

Equity markets have had a rough go of it this year due to President Trumps macroeconomic policies. Though it can…

Viking Therapeutics: A Lot More Compelling After The Meltdown - Initiating Cautious Buy (Rating Upgrade)

…

Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market

…

Viking Therapeutics VK2735 Candidate Likely Boosted By Pfizers Woes

…

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ:…

3 Magnificent Stocks That Could Double or More by 2030

When the stock market is as turbulent as it is these days, its easy to forget the times when things…

Viking Therapeutics Aktie: VK2735 als Hoffnungsträger mit modernem Wirkansatz

New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von Goldman Sachs: Richard Law, Analyst von Goldman Sachs, nimmt die Coverage der Aktie von…

The Smartest Biotech Stocks to Buy With $50

One of the great things about equity markets is that you dont need a fortune to get started. Though strong…

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $23.91, marking a -0.99% move from the previous day.…

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.28, indicating a +1.14% shift from the previous…

Motley Fool 2025 March Market Cap Showdown Championship

It all comes down to this...the final round of the Motley Fool Rule Breaker Investing March Market Cap Showdown! Defending…

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

Its hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug…

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually…

Why Novo Nordisk Stock Outpaced the Market on Tuesday

Novo Nordisk (NYSE: NVO), the Danish company best known as the maker of weight loss drug Wegovy, expanded a little…

An Ozempic successor falls short, Eli Lillys GLP-1 pill, and senators grill RFK: Pharma news roundup

Plus, Eli Lillys CEO got a pay raise, and Viking Therapeutics gets closer to bringing its Ozempic competitor to market…

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $29.73, denoting a +0.61% change from…

Viking Therapeutics: No Buyout Needed Now

…

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics.…

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply

The deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its obesity…

Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade)

…

Is Eli Lilly Stock a Buy?

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and its an element you…

The State of Weight Loss Drugs

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They…

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Last year, Viking Therapeutics, a mid-cap biotech, made waves after it reported excellent phase 2 results for an investigational medicine…

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.10, indicating a +1.46% shift from the previous…

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $28.87, denoting a +0.7% change from…

1 Biotech Stock to Buy in 2025, and 1 to Avoid

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.…

Prediction: Novo Nordisk Will Soar Over the Next 5 Years. Heres 1 Reason Why.

After quite a crushing bull stampede in 2024, the stock price of weight loss drug star Novo Nordisk (NYSE: NVO)…

Should You Buy VKTX Stock Amid Renewed M&A Speculations?

Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics, regardless of buyout speculations.…

Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and Its Not Eli Lilly or Novo Nordisk

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly…

dpa-AFX ProFeed